Gould Capital »

Emergent BioSolutions shares owned by Gould Capital

Quarter-by-quarter ownership of Emergent BioSolutions (EBS) shares owned by Gould Capital from 13F filings

Historical chart of Gould Capital investment in Emergent BioSolutions

Tip: Access up to 7 years of quarterly data

All positions including Emergent BioSolutions held by Gould Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Emergent BioSolutions by Gould Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $682 100 6.82
2024-03-31 $253 100 2.53
2023-12-31 $240 100 2.40
2023-09-30 $316 100 3.16
2023-06-30 $735 100 7.35

More positions owned by Gould Capital

Ishares 3-7 Year Treasury Bond Etf Etf (IEI)
Vanguard Total Bond Market Etf Etf (BND)
Vanguard Ftse Developed Markets Etf Etf (VEA)
Vanguard Total International Bond Etf Etf (BNDX)
Apple Stock (AAPL)
Microsoft Corp Stock (MSFT)
Spdr Gold Shares Etf (GLD)
Union Pac Corp Stock (UNP)
Vanguard Ftse Emerging Markets Etf Etf (VWO)
Ishares Short Treasury Bond Etf Etf (SHV)
Alphabet Inc Cap Stk Cl C Stock (GOOG)
Berkshire Hathaway Inc Del Cl B Stock (BRK.B)
Bank New York Mellon Corp Stock (BK)
Aflac Stock (AFL)
Verizon Communications Stock (VZ)

View all positions for Gould Capital

Top funds holding Emergent BioSolutions

BlackRock
Vanguard Group
Charles Schwab Investment Management
Morgan Stanley
Millennium Management
Invesco
American Century Companies
Connor, Clark & Lunn Investment Management
D. E. Shaw & Co
Assenagon Asset Management
Hanna Zanoni
Jpmorgan Chase & Co
Goldman Sachs Group
Two Sigma Advisers
Geode Capital Management

View all funds holding Emergent BioSolutions